CD44‐Targeting Drug Delivery System of Exosomes Loading Forsythiaside A Combats Liver Fibrosis via Regulating NLRP3‐Mediated Pyroptosis
2023 · Advanced Healthcare Materials · 75 citations
https://doi.org/10.1002/adhm.202202228
H
Honglin Zhou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
60
Papers
7.4K
Citations
28
h-index
39
i10-index
Honglin Zhou is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Cervical Cancer and HPV Research & Cancer-related molecular mechanisms research. The author has an h-index of 28, co-authored 51 publications.
ORCID: 0000-0001-5966-8476Papers by this author
worksPhillygenin inhibited M1 macrophage polarization and reduced hepatic stellate cell activation by inhibiting macrophage exosomal miR-125b-5p
2023 · Biomedicine & Pharmacotherapy · 51 citations
https://doi.org/10.1016/j.biopha.2023.114264
Mesenchymal stem cell-derived exosomes and non-coding RNAs: Regulatory and therapeutic role in liver diseases
2022 · Biomedicine & Pharmacotherapy · 27 citations
https://doi.org/10.1016/j.biopha.2022.114040
Human papillomavirus and human telomerase RNA component gene in cervical cancer progression
2019 · Scientific Reports · 19 citations
https://doi.org/10.1038/s41598-019-52195-5
Junctional and somatic hypermutation-induced CX4C motif is critical for the recognition of a highly conserved epitope on HCV E2 by a human broadly neutralizing antibody
2020 · Cellular and Molecular Immunology · 18 citations
https://doi.org/10.1038/s41423-020-0403-1
Preparation of Phillygenin-Hyaluronic acid composite milk-derived exosomes and its anti-hepatic fibrosis effect
2023 · Materials Today Bio · 14 citations
https://doi.org/10.1016/j.mtbio.2023.100804
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat